688739.SHG Liaoning Chengda Biotechnology Co. Ltd. A

Healthcare Biotechnology Shanghai Stock Exchange
20.83 CNY
Close of Nov 4, 2026
18.91 28.30
Market cap
CNY 8.67B
P/E
130.2x
P/B
0.93x
ROE
0.7%
Dividend yield
3.80%
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 688739.SHG undervalued?

Graham number
Price20.83
Graham value9.00
Premium131.6%

688739.SHG trades 131.6% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Liaoning Chengda Biotechnology Co. Ltd. A fundamental analysis

No fundamental analysis for Liaoning Chengda Biotechnology Co. Ltd. A yet.

Liaoning Chengda Biotechnology Co. Ltd. A stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Liaoning Chengda Biotechnology Co. Ltd. A

Liaoning Chengda Biotechnology Co., Ltd., a biopharmaceutical company, engages in the research, development, production, and sale of vaccines in China and internationally. It offers inactivated Japanese encephalitis and SPEEDA-rabies vaccines. The company also develops rabies vaccine which is in new drug approval stage; influenza vaccine which is in new drug application stage; recombinant human papillomavirus 15-valent vaccine which is in Phase II clinical stage; and 13-vale…

Full company profile